logo-loader
viewCB2 Insights Inc.

CB2 Insights acquires medical cannabis clinic group in Colorado and Arizona

CB2 Insights (CBII) CEO Prad Sekar joined Steve Darling from proactive Investors on Skype to discuss CB2’s acquisition of MedEval Clinic LLC, a medical cannabis evaluation and education center group with multiple locations in Colorado and Arizona.

Sekar discussed why they decided to do the deal and how it fits in the overall strategy at CB2. Sekar also addressed the clinics model and revenue expected to be generated. 

Quick facts: CB2 Insights Inc.

Price: 0.13 CAD

CSE:CBII
Market: CSE
Market Cap: $10.4 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of CB2 Insights Inc. named herein, including the promotion by the Company of CB2 Insights Inc. in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights announces key partnership with GL Brands for...

CB2 Insights ((CSE: CBII; OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from our Toronto studio to provide details the will begin a prospective trial with GL Brands that will assess the safety, efficacy and other health measures for patients using Green Lotus’ cannabidiol soft gel capsules...

on 12/17/2019

2 min read